Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (27)	3/2/1998 12:12:00 PM
From: aknahow	Respond to of 415

I believe Lamperts' action is significant. He probably knows a lot more than any of any of us could ever hope to know about their licensing agreements. I could buy MCDE because he owns it but still would feel uncomfortable without knowing what royalties they will receive if products are successful. I looked at MCDE as a means of diversification into what many believe is an attractive area. The stock will probably do very well. Appreciate this thread and I will continue to lurk.